Eben Tessari - 10 Jun 2021 Form 3 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role
Chief Business Officer
Signature
/s/ Eben Tessari
Issuer symbol
KNSA
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
3
Filing time
21 Jun 2021, 17:37:13 UTC
Next filing
18 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KNSA Class A Common Shares 105,942 10 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KNSA Share Option 10 Jun 2021 Class A Common Shares 56,673 $1.59 Direct F1
holding KNSA Share Option 10 Jun 2021 Class A Common Shares 35,049 $3.80 Direct F2
holding KNSA Share Option 10 Jun 2021 Class A Common Shares 109,795 $10.36 Direct F3
holding KNSA Share Option 10 Jun 2021 Class A Common Shares 45,000 $30.93 Direct F4
holding KNSA Share Option 10 Jun 2021 Class A Common Shares 42,000 $17.92 Direct F5
holding KNSA Share Option 10 Jun 2021 Class A Common Shares 45,000 $8.83 Direct F6
holding KNSA Share Option 10 Jun 2021 Class A Common Shares 60,000 $15.52 Direct F7
holding KNSA Share Option 10 Jun 2021 Class A Common Shares 60,000 $15.50 Direct F8
holding KNSA Share Option 10 Jun 2021 Class A Common Shares 47,138 $22.89 Direct F9
holding KNSA Restricted Share Units 10 Jun 2021 Class A Common Shares 7,856 Direct F10, F11
holding KNSA Restricted Share Units 10 Jun 2021 Class A Common Shares 4,611 Direct F11, F12
holding KNSA Restricted Share Units 10 Jun 2021 Class A Common Shares 2,982 Direct F11, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested and exercisable.
F2 The option will become fully vested and exercisable on June 28, 2021.
F3 The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is March 1, 2018.
F4 The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is September 20, 2018.
F5 The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is March 4, 2019.
F6 The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is September 17, 2019.
F7 The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is March 13, 2020.
F8 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is September 10, 2020.
F9 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is March 16, 2021.
F10 The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.
F11 Each RSU represents a contingent right to receive one Class A Common Share of the Issuer.
F12 The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2022, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.
F13 The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2023, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.

Remarks:

Exhibit 24 - Power of Attorney.